Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis

Osteoporos Int. 2022 Nov;33(11):2441-2443. doi: 10.1007/s00198-022-06545-1. Epub 2022 Sep 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Bone Density
  • Bone Density Conservation Agents* / therapeutic use
  • Female
  • Humans
  • Osteoporosis, Postmenopausal* / drug therapy

Substances

  • Antibodies, Monoclonal
  • Bone Density Conservation Agents
  • romosozumab